home / stock / dmpi / dmpi quote
Last: | $1.34 |
---|---|
Change Percent: | 7.2% |
Open: | $1.22 |
Close: | $1.34 |
High: | $1.35 |
Low: | $1.17 |
Volume: | 1,321,048 |
Last Trade Date Time: | 08/19/2020 04:58:56 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.34 | $1.22 | $1.34 | $1.35 | $1.17 | 1,321,048 | 08-19-2020 |
$1.25 | $1.16 | $1.25 | $1.285 | $1.16 | 1,067,795 | 08-18-2020 |
$1.16 | $1.28 | $1.16 | $1.31 | $1.0933 | 2,871,179 | 08-17-2020 |
$1.16 | $1.18 | $1.16 | $1.3 | $1.145 | 1,073,786 | 08-14-2020 |
$1.16 | $1.15 | $1.16 | $1.22 | $1.07 | 781,756 | 08-13-2020 |
$1.24 | $1.29 | $1.24 | $1.34 | $1.12 | 1,475,278 | 08-12-2020 |
$1.26 | $1.23 | $1.26 | $1.53 | $1.2 | 6,705,884 | 08-11-2020 |
$1.18 | $1.11 | $1.18 | $1.19 | $1.1 | 911,630 | 08-10-2020 |
$1.06 | $1.05 | $1.06 | $1.06 | $0.993 | 256,857 | 08-07-2020 |
$1.03 | $1.05 | $1.03 | $1.07 | $1 | 403,405 | 08-06-2020 |
$1.04 | $0.93 | $1.04 | $1.05 | $0.93 | 524,270 | 08-05-2020 |
$0.95 | $0.94 | $0.95 | $0.95 | $0.9001 | 143,630 | 08-04-2020 |
$0.9418 | $0.92 | $0.9418 | $0.981 | $0.861 | 367,576 | 08-03-2020 |
$0.9537 | $1.02 | $0.9537 | $1.0301 | $0.93 | 540,426 | 07-31-2020 |
$1.03 | $1.02 | $1.03 | $1.06 | $1 | 505,073 | 07-30-2020 |
$1.06 | $1.03 | $1.06 | $1.15 | $0.982 | 1,592,731 | 07-29-2020 |
$1.05 | $1.01 | $1.05 | $1.09 | $0.93 | 1,179,088 | 07-28-2020 |
$1.04 | $0.94 | $1.04 | $1.07 | $0.8522 | 2,101,250 | 07-27-2020 |
$1.005 | $0.95 | $1.005 | $1.05 | $0.95 | 1,118,526 | 07-24-2020 |
$1.12 | $1.24 | $1.12 | $1.26 | $1.08 | 1,378,679 | 07-23-2020 |
News, Short Squeeze, Breakout and More Instantly...
DelMar Pharmaceuticals Company Name:
DMPI Stock Symbol:
NASDAQ Market:
SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...